Education
About Us
Working with TipRanks
Follow Us
Edward Hurwitz Insider Profile
4 Followers
Edward Hurwitz, Director at MacroGenics, holds 44.07K shares in MacroGenics (Ticker: MGNX), holds 0.00 shares in Applied Genetic Technologies (Ticker: AGTC), holds 91.08K shares in Dyne Therapeutics (Ticker: DYN).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-15.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Edward Hurwitz holds in companies
Most Profitable Insider Trade
The most profitable trade made by Edward Hurwitz
Edward Hurwitz's Trading History
MacroGenics
May 22, 2025
Director
Uninformative Buy
10.21K
$77.13K
Dyne Therapeutics
Sep 23, 2020
Director
Uninformative Buy
―
$1.34M
Applied Genetic Technologies
Dec 01, 2022
―
Uninformative Sell
―
$0.00
Viracta Therapeutics
Jul 01, 2010
―
Uninformative Buy
3.22M
$3.82K
Tvardi Therapeutics
―
Director, Ten Percent Owner
―
$0.00
List of latest transactions for each holding click on a transaction to see Edward Hurwitz's performance on stock
You May Also Like
Edward Hurwitz insider profile FAQ
What is the percentage of profitable transactions made by Edward Hurwitz?
The percentage of profitable transactions made by Edward Hurwitz is 0%.
What is the average return per transaction made by Edward Hurwitz?
The average return per transaction made by Edward Hurwitz is -15.80%.
What stocks does Edward Hurwitz hold?
Edward Hurwitz holds: MGNX, DYN, AGTC, VIRX, TVRD stocks.
What was Edward Hurwitz’s latest transaction?
Edward Hurwitz latest transaction was an Uninformative Buy of $10.21K.
What was Edward Hurwitz's most profitable transaction?
Edward Hurwitz’s most profitable transaction was an Informative Sell of MGNX stock on February 18, 2014. The return on the trade was -3.90%.
What is Edward Hurwitz's role in MacroGenics?
Edward Hurwitz's role in MacroGenics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.